Clínica Baviera, S.A.

MCE CBAV.MC

Clínica Baviera, S.A. Free Cash Flow for the year ending December 31, 2023: USD 38.78 M

Clínica Baviera, S.A. Free Cash Flow is USD 38.78 M for the year ending December 31, 2023, a -7.89% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Clínica Baviera, S.A. Free Cash Flow for the year ending December 31, 2022 was USD 42.10 M, a 1.93% change year over year.
  • Clínica Baviera, S.A. Free Cash Flow for the year ending December 31, 2021 was USD 41.30 M, a 43.04% change year over year.
  • Clínica Baviera, S.A. Free Cash Flow for the year ending December 31, 2020 was USD 28.87 M, a 58.71% change year over year.
  • Clínica Baviera, S.A. Free Cash Flow for the year ending December 31, 2019 was USD 18.19 M, a 114.61% change year over year.
Key data
Date Free Cash Flow Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities
Market news
Loading...
MCE: CBAV.MC

Clínica Baviera, S.A.

CEO Mr. Eduardo Baviera Sabater
IPO Date April 3, 2007
Location Spain
Headquarters Paseo de la Castellana 20
Employees 1,326
Sector Health Care
Industries
Description

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, vías lagrimales, and oculoplasty treatments. It operates approximately 90 centers in Spain, Germany, Austria, and Italy. The company is based in Madrid, Spain.

Similar companies

CAF.MC

Construcciones y Auxiliar de Ferrocarriles, S.A.

USD 36.07

0.46%

VID.MC

Vidrala, S.A.

USD 91.52

-0.29%

FAE.MC

Faes Farma, S.A.

USD 3.46

-1.45%

MCM.MC

Miquel y Costas & Miquel, S.A.

USD 12.78

0.60%

AZK.MC

Azkoyen, S.A.

USD 6.55

2.87%

StockViz Staff

January 15, 2025

Any question? Send us an email